alexa Novel Signaling Paradigm Regulating TOLL-like Receptors In Innate Immune Cells
ISSN: 2155-9899

Journal of Clinical & Cellular Immunology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference and Exhibition on Clinical & Cellular Immunology
September 29-October 01, 2014 DoubleTree by Hilton Baltimore-BWI Airport, USA

Myron R Szewczuk and Samar Abdulkhalek
ScientificTracks Abstracts: J Clin Cell Immunol
DOI: 10.4172/2155-9899.S1.017
Abstract
Toll like receptors (TLRs) are essential sensors of microbial attack, and they orchestrate the innate immune response against many microorganisms. The signaling pathways of these mammalian TLRs are well characterized, but the initial molecular mechanisms activated following ligand interactions with their receptors remain poorly defined. Here, we report a novel signaling paradigm initiated by binding of specific TLR ligands (LPS for TLR4, imiquimodfor TLR7, and CpG for TLR9 ) to potentiate G protein-coupled receptor and matrix metalloproteinase-9 (MMP9) activation to induce mammalian Neu1 sialidase. Central to this process is that Neu1-MMP9 complex is bound to TLR-4, -7 and -9 in naive and ligand stimulated macrophage cells as revealed by co-immunoprecipitation and colocalization assays. Using NFκB dependent secreted alkaline phosphatase (SEAP) analysis, ligand-induced TLR activation was significantly inhibited by oseltamivir phosphate (OP), MMP9 inhibitor and BIM- 23127 (a specific NMBR inhibitor). Mal-2 lectin (Maackiaamurensis agglutinin) binding to immunoprecipitated TLRs in cell lysates from naive but not TLR ligand stimulated RAW-blue macrophage cellsindicated the removal of the α-2,3 sialic acid residues from the stimulated receptor ectodomain. OP, MMP9 inhibitor and BIM-23127 blocked MyD88 recruitment to the ligand stimulated TLR receptors. This study reveals an novel identical GPCR signaling platform to potentiate Neu1 and MMP9 cross-talk on the cell surface and in the endosomal compartments of macrophages that is essential for Toll-like receptor activation, cellular signaling and pro-inflammatory responses. Supported by NSERC to MS and CIHR doctoral award to SA.
Biography
Myron R Szewczuk received his PhD (Biology and Immunochemistry) from the University of Windsor, Windsor Ontario in 1974 and completed his postdoctoral studies in Cellular Immunologyunder Dr. Gregory W.Siskind at Cornell University Medical College, New York City, in 1978. From 1978-81, Dr. Szewczuk was an Assistant Professor of Pathology at McMaster University, Hamilton, Ontario. In 1981, he joined the Dept. of Microbiology & Immunology (now Biomedical and Molecular Sciences) as an Associate Professor of Immunology at Queen?s University, Kingston, Ontario. In 1986, he received tenure and became full Professor of Immunology and Associate Professor of Medicine. He is presently a full time faculty member at Queen?s University with an active teaching and research program in immunology and cancer. He has published over 100 papers, chapters and reviews primarily in the field of immunology and cancer.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords